Company positions itself as the central research hub for patients, clinicians, and compounding pharmacies tracking the ...
A trial of 108 adults with obesity seeking treatment for alcohol use finds a once-weekly semaglutide injection reduced heavy ...
We summarized existing research on weight loss medications in rheumatic disease and their potential for improving quality of ...
GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss. As more people look into these prescriptions, there is growing curiosity about how ...
Could preserved vision be part of the growing list of health benefits associated with GLP-1 drug use? New research suggests that in patients without diabetes, GLP-1 medications may lower the risk of ...
The U.S. Food and Drug Administration on Wednesday approved a second oral GLP-1 medication, giving adults eligible for weight loss medication another option. The new pill, called Foundayo, is made by ...
The number of Americans using weight-loss drugs such as Ozempic has increased to about 12.4 percent. Restaurateurs are taking ...
New IGD (Institute of Grocery Distribution) research reveals that uptake of GLP1 weight loss medications has almost doubled in the UK since June 2025, rising from 3.1% to 6% in March this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results